Di-substituted amides for enhancing glutamatergic synaptic responses

Details for Australian Patent Application No. 2008254960 (hide)

Owner Cortex Pharmaceuticals, Inc.

Inventors Lee, Stephen; Street, Leslie; Mueller, Rudolf

Agent A.P.T. Patent and Trade Mark Attorneys

Pub. Number AU-A-2008254960

PCT Pub. Number WO2008/143963

Priority 60/958,069 02.07.07 US; 60/930,633 17.05.07 US

Filing date 16 May 2008

Wipo publication date 27 November 2008

International Classifications

A01N 43/82 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

Event Publications

7 January 2010 PCT application entered the National Phase

  PCT publication WO2008/143963 Priority application(s): WO2008/143963

12 August 2010 Assignment before Grant

  Cortex Pharmaceuticals, Inc. The application has been assigned to Biovail Laboratories International SRL 2010

16 June 2011 Assignment before Grant

  Biovail Laboratories International SRL The application has been assigned to Cortex Pharmaceuticals, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008254961-Temperature swing adsorption of CO2 from flue gas utilizing heat from compression

2008254957-Ziprasidone formulations